| 000 | 01329 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513091932.0 | ||
| 264 | 0 | _c19960807 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/88.14.1002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMénard, S | |
| 245 | 0 | 0 |
_aNo additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cJul 1996 |
||
| 300 |
_a1002-3 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, erbB-2 _xgenetics |
| 650 | 0 | 4 |
_aGenes, p53 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aCasalini, P | |
| 700 | 1 | _aPilotti, S | |
| 700 | 1 | _aCascinelli, N | |
| 700 | 1 | _aRilke, F | |
| 700 | 1 | _aColnaghi, M I | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 88 _gno. 14 _gp. 1002-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/88.14.1002 _zAvailable from publisher's website |
| 999 |
_c8665725 _d8665725 |
||